摘要 |
<p>This invention relates to the use of compounds of formula (I) wherein R?1, R2, R3, R4 and R5¿ are as defined in the description, A signifies -CH=CH- or -C=C-; and B signifies (B1); (B2); (B3); (B4); (B5) or (B6); wherein R?6 to R26¿, X and Y have the significances given in the description, as well as pharmaceutically acceptable salts thereof, for the manufacture of medicaments for the treatment or prevention of mGluR5 receptor mediated disorders.</p> |